Retrospective analysis supports algorithm as efficient diagnostic approach to treatable intellectual developmental disabilities

作者: Bryan Sayson , Marioara Angela Moisa Popurs , Mirafe Lafek , Ruth Berkow , Sylvia Stockler-Ipsiroglu

DOI: 10.1016/J.YMGME.2015.03.001

关键词: Exome sequencingPediatricsPopulationCost effectivenessMedical diagnosisHealth careIntellectual disabilityMedicineGlobal developmental delayProspective cohort study

摘要: Abstract Background Intellectual developmental disorders (IDD 1 1Abbreviations:Intellectual (IDD)Inborn Errors of Metabolism (IEM)Treatable Disability Endeavour (TIDE)Whole Exome Sequencing (WES).), characterized by a significant impairment in cognitive function and behavior, affect 2.5% the population are associated with considerable morbidity healthcare costs. Inborn errors metabolism (IEM) currently constitute largest group genetic defects presenting IDD, which amenable to causal therapy. Recently, we created an evidence-based 2-tiered diagnostic protocol (TIDE protocol); first tier is ‘screening step' applied all patients, comprising routinely performed, wide available metabolic tests blood urine, while second-tier more specific based on patient's phenotype. The supported app (www.treatable-ID.org). Objective To retrospectively examine cost- time-effectiveness TIDE patients identified treatable IEM at British Columbia Children's Hospital. Methods We searched database for IDD diagnosed IEM, during period 2000–2009 our academic institution. Data regarding clinical phenotype, interval were collected. Total costs time intervals testing physician consultations actually performed calculated compared model protocol. Results Thirty-one (16 males) 2000–2009. For those identifiable via 1st ( n =20), average cost savings would have been $311.17 CAD, test =11) $340.14 CAD. Significant delay (mean 9months; range 1–29 months) could avoided 9 first-tier diagnoses, had used. diagnoses rapidly achieved use Treatable allowing searches signs symptoms. Conclusion forms appears effective reducing unnecessary Larger prospective studies, underway, needed prove that standard screening conditions time- cost-effective, most importantly will preserve brain timely diagnosis enabling initiation

参考文章(33)
Sylvia Stockler, Peter W. Schutz, Gajja S. Salomons, Cerebral creatine deficiency syndromes: clinical aspects, treatment and pathophysiology. Sub-cellular biochemistry. ,vol. 46, pp. 149- 166 ,(2007) , 10.1007/978-1-4020-6486-9_8
S. Esmaeeli-Nieh, E.H. Sherr, Mental Retardation/Intellectual Disability Encyclopedia of the Neurological Sciences (Second Edition). pp. 1090- 1094 ,(2014) , 10.1016/B978-0-12-385157-4.00436-X
LUIS SALVADOR CARULLA, GEOFFREY M. REED, LEILA M. VAEZ-AZIZI, SALLY-ANN COOPER, RAFAEL MARTINEZ LEAL, MARCO BERTELLI, COLLEEN ADNAMS, SHERVA COORAY, SHOUMITRO DEB, LEYLA AKOURY DIRANI, SATISH CHANDRA GIRIMAJI, GREGORIO KATZ, HENRY KWOK, RUTH LUCKASSON, RUNE SIMEONSSON, CAROLYN WALSH, KEMIR MUNIR, SHEKHAR SAXENA, Intellectual developmental disorders: towards a new name, definition and framework for "mental retardation/intellectual disability" in ICD-11. World Psychiatry. ,vol. 10, pp. 175- 180 ,(2011) , 10.1002/J.2051-5545.2011.TB00045.X
Melanie Manning, Louanne Hudgins, Professional Practice and Guidelines Committee, None, Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities Genetics in Medicine. ,vol. 12, pp. 742- 745 ,(2010) , 10.1097/GIM.0B013E3181F8BAAD
Christopher M. Doran, Stewart L. Einfeld, Rosamond H. Madden, Michael Otim, Siân K. Horstead, Louise A. Ellis, Eric Emerson, How much does intellectual disability really cost? First estimates for Australia Journal of Intellectual & Developmental Disability. ,vol. 37, pp. 42- 49 ,(2012) , 10.3109/13668250.2011.648609
Clara D.M. van Karnebeek, Sylvia Stockler, Treatable inborn errors of metabolism causing intellectual disability: A systematic literature review Molecular Genetics and Metabolism. ,vol. 105, pp. 368- 381 ,(2012) , 10.1016/J.YMGME.2011.11.191
Clara D.M. van Karnebeek, Michael Shevell, Johannes Zschocke, John B. Moeschler, Sylvia Stockler, The metabolic evaluation of the child with an intellectual developmental disorder: Diagnostic algorithm for identification of treatable causes and new digital resource Molecular Genetics and Metabolism. ,vol. 111, pp. 428- 438 ,(2014) , 10.1016/J.YMGME.2014.01.011
Sian Ellard, George P. Patrinos, William S. Oetting, Clinical applications of next-generation sequencing: the 2013 human genome variation society scientific meeting. Human Mutation. ,vol. 34, pp. 1583- 1587 ,(2013) , 10.1002/HUMU.22400
Katja Lohmann, Christine Klein, Next Generation Sequencing and the Future of Genetic Diagnosis Neurotherapeutics. ,vol. 11, pp. 699- 707 ,(2014) , 10.1007/S13311-014-0288-8
Clara D. van Karnebeek, William S. Sly, Colin J. Ross, Ramona Salvarinova, Joy Yaplito-Lee, Saikat Santra, Casper Shyr, Gabriella A. Horvath, Patrice Eydoux, Anna M. Lehman, Virginie Bernard, Theresa Newlove, Henry Ukpeh, Anupam Chakrapani, Mary Anne Preece, Sarah Ball, James Pitt, Hilary D. Vallance, Marion Coulter-Mackie, Hien Nguyen, Lin-Hua Zhang, Amit P. Bhavsar, Graham Sinclair, Abdul Waheed, Wyeth W. Wasserman, Sylvia Stockler-Ipsiroglu, Mitochondrial carbonic anhydrase VA deficiency resulting from CA5A alterations presents with hyperammonemia in early childhood. American Journal of Human Genetics. ,vol. 94, pp. 453- 461 ,(2014) , 10.1016/J.AJHG.2014.01.006